Please assess the completion status of the following clinical trial:

Trial Title: Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects, aged less than 85 years inclusive.~* Subjects who have cuff tear arthropathy, osteoarthritis with cuff deficiency, rheumatoid arthritis, post traumatic injury, or a need for revision surgery of a failed anatomic prosthesis in the left or right shoulder, which requires (total) shoulder arthroplasty.~* Subjects with radiographic evidence of sufficient bone stock to seat and support the Delta XtendÔ Reverse Total Shoulder System.~* Subjects who in the opinion of the Clinical Investigator are considered suitable for treatment with the Delta Xtend Reverse Total Shoulder System.~* Patients with a life expectancy of greater than 12 months.~* Subjects who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained.~* Subjects who, in the opinion of the Clinical Investigator, are able to understand this clinical investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.~Exclusion Criteria:~* Male and female subjects aged 86 years or older.~* Subjects with complete deltoid muscle palsy in the target joint as determined by clinical evaluation.~* Subjects with active local or systemic infection or with a history of general or local infections in the target joint over the past 12 months.~* Subjects with severe deformities, or tumours, that would impair fixation or proper positioning of the implant.~* Subjects with no significant muscle, nerve or vascular disease.~* Subjects with a pathology that, in the opinion of the Clinical Investigator, will adversely affect healing.~* Known allergic reactions to implant materials (e.g. bone cement, metal, polyethylene) implant corrosion or implant wear debris.~* Subjects with a known history of poor compliance to medical treatment.~* Subjects who, in the opinion of the Clinical Investigator, have an existing condition that would compromise their participation and follow-up in this clinical investigation.~* Women who are pregnant.~* Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.~* Subjects who have participated in a clinical investigation with an investigational product in the last month.~* Subjects who are currently involved in any injury litigation claims.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Delta Xtend Reverse Total Shoulder (Type: OTHER): Orthopaedic implant for total shoulder replacement

Based on this trial design, predict the completion outcome and termination type (if applicable).